Department of Urology, Zhujiang Hospital of Southern Medical University, Guangzhou, People’s Republic of China.
Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital of Southern Medical University, Guangzhou, People’s Republic of China.
Aging (Albany NY). 2020 Nov 20;12(23):23668-23683. doi: 10.18632/aging.103820.
The role of DNA methyltransferase 3B (DNMT3B) in tumorigenesis and development has been widely recognized; however, the mechanism underlying its action remains unclear. Considering its function in methylation, we aimed to investigate whether DNMT3B plays its role via microRNA (miR)-34a promoter methylation in bladder cancer. We found that DNMT3B expression was low in 10 bladder cancer tissues and high in 20 bladder cancer tissues. miR-34a expression was higher in bladder cancer tissues with low expression of DNMT3B than that in bladder cancer tissues with high expression of DNMT3B. The level of miR-34a was negatively correlated with the level of DNMT3B. The methylation ratio of the miR-34a promoter was positively correlated with the level of DNMT3B and negatively correlated with the level of miR-34a. knockdown increased the expression of miR-34a and the transcriptional activity of the miR-34a promoter, while decreasing miR-34a promoter methylation. knockdown inhibited migration and invasion, while decreasing the protein levels of hepatocyte nuclear factor 4 gamma and Notch1 which are downstream targets of miR-34a. These inhibitory effects of DNMT3B were mitigated by the miR-34a inhibitor. In conclusion, DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
DNA 甲基转移酶 3B(DNMT3B)在肿瘤发生和发展中的作用已得到广泛认可;然而,其作用机制尚不清楚。鉴于其在甲基化中的功能,我们旨在研究 DNMT3B 是否通过 miR-34a 启动子甲基化在膀胱癌中发挥作用。我们发现,10 例膀胱癌组织中 DNMT3B 表达较低,20 例膀胱癌组织中 DNMT3B 表达较高。miR-34a 在 DNMT3B 低表达的膀胱癌组织中表达高于 DNMT3B 高表达的膀胱癌组织。miR-34a 的水平与 DNMT3B 的水平呈负相关。miR-34a 启动子的甲基化比例与 DNMT3B 的水平呈正相关,与 miR-34a 的水平呈负相关。DNMT3B 的敲低增加了 miR-34a 的表达和 miR-34a 启动子的转录活性,同时降低了 miR-34a 启动子的甲基化。DNMT3B 的敲低抑制了迁移和侵袭,同时降低了 miR-34a 的下游靶蛋白肝细胞核因子 4 伽马和 Notch1 的蛋白水平。miR-34a 抑制剂减轻了 DNMT3B 的这些抑制作用。总之,DNMT3B 沉默通过表观遗传促进膀胱癌中 miR-34a 的表达来抑制迁移和侵袭。